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Abstract: Inflammation represents an adaptive response generated by injuries or harmful stimuli.
Natural remedies represent an interesting alternative to traditional therapies, involving several
biochemical pathways. Besides, the valorization of agrochemical wastes nowadays seems to
be a feasible way to reduce the health spending and improve the accessibility at bioactive
natural compounds. In this context, the chemical composition of three Glycyrrhiza glabra L.
(licorice) leaf extracts, obtained through maceration or ultrasound-assisted method (fresh and dried
leaves) was investigated. A guided fractionation obtained three main components: pinocembrin,
glabranin and licoflavanone. All the extracts showed similar antioxidant properties, evaluated
by 2,2′-diphenyl-1-picrylhydrazyl (DPPH) or 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)
Diammonium Salt (ABTS) assay, while, among the isolated compounds, licoflavanone exhibited the
best antioxidant activity. The anti-inflammatory activity of the extracts and the purified compounds
was investigated in lipopolysaccharide (LPS)-stimulated RAW 264.7 murine macrophages. Extract
C and licoflavanone showed a good anti-inflammatory activity without affecting cell viability, as
they decreased nitrite levels even when used at 12.5 µg/mL (p < 0.005) and 50 µM concentration
(p < 0.001), respectively. Interestingly, licoflavanone markedly decreased pro-inflammatory cytokines
and cyclooxygenase 2/inducible nitric oxide synthase (COX-2/iNOS) expression levels (p < 0.001).
A modulation of nuclear factor kappa B/mitogen-activated protein kinases (NF-kB/MAPK) pathway
underlay such behavior, highlighting the potential of this natural compound as a new scaffold in
anti-inflammatory drug research.
Keywords: pinocembrin; licoflavanone; Glycyrrhiza glabra; antioxidant activity; anti-inflammatory
activity; NF-kB/MAPK pathway
1. Introduction
Inflammation is a physio-pathological condition characterized by a complex biological response
of body tissues to physical, chemical and biological stimuli. This process involves immune cells,
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blood vessels and molecular mediators in order to remove damage and to start tissue repair but,
on the other hand, chronic inflammation can favor the onset of various diseases [1,2]. Over the
years, many anti-inflammatory drugs have been developed with the aim to reduce inflammatory
mediators’ levels in the body [3]. Most of these molecules act as cyclooxygenase (COX) inhibitors.
They belong to a class of drugs that evolved over time to include selective inhibitors of COX-2, the
isoform induced in inflammatory conditions, in order to reduce side effects of traditional nonsteroidal
anti-inflammatory drugs (NSAID) therapy [4]. In addition, in the last decades, many natural
compounds were used as templates for the development of new anti-inflammatory agents [5–7].
Plant phenols, particularly flavonoids, feature a wide range of biological activity, mainly including
antioxidant and anti-inflammatory activity, useful as alternative medicaments [8–11]. Many studies
highlighted that different phytocomplexes derived from Glycyrrhiza glabra L. are endowed with multiple
biological activities, including antioxidant and anti-inflammatory activity, which were studied in
different experimental models [12–14]. Although for a long time the most utilized parts of G. glabra
were the roots, many studies reported that also its aerial parts, usually treated as an agrochemical
waste, contained many bioactive compounds such as dihydrostilbenes [15–17], pinocembrin [18,19],
licoflavanone, formononetin, isoquercitrin, genistein, prunetin, wighteone, 6-prenylnaringenin and
lupiwighteone [19].
Dihydrostilbenes derived from Glycyrrhiza glabra leaves are structurally related to flavonoids
and exhibit antigenotoxic, antioxidant and anti-inflammatory activity [16,17]. In previous studies,
performed on autochthonous Glycyrrhiza glabra L., pinocembrin was recovered in leaf extracts, also
assayed for their anti-proliferative, antioxidant and antibacterial activities [18,20]. Pinocembrin
resulted as the principal component of the total extract, recoverable from methanol fraction after
column chromatography. Literature data report that pinocembrin is a flavonoid endowed with
antioxidant [21] and anti-inflammatory properties, exerted by downregulating tumor necrosis factor
alpha (TNF-α), interleukin 1 beta (IL-1β), and interleukin 6 (IL-6). These activities are also achieved by
significantly suppressing the phosphorylation and activation of extracellular signal-regulated kinase
(ERK), c-Jun NH2-terminal kinase (JNK) and p38MAPK, as well as by reducing the phosphorylation
of IkBα, directly involved in nuclear factor kappa B (NF-kB) regulation, as demonstrated by in vitro
and in vivo studies [22]. In Glycyrrhiza glabra L. extracts, several bioactive metabolites were also
identified [23], including flavonoids able to inhibit the production of nitric oxide (NO), interleukin-6
(IL-6) and prostaglandin E2 (PGE2) in lipopolysaccharide (LPS)-induced macrophages [24]. In this
work, an efficient and fast method to recover pinocembrin, an emergent tool in pharmaceutical
research [25], was firstly apprehended. For this purpose, ultrasound-assisted extraction (UAE) was
applied both to fresh and dried leaves of Glycyrrhiza glabra. Furthermore, this procedure allowed us to
isolate two prenylated flavanones, known as glabranin and licoflavanone, whose anti-inflammatory
activities were also tested. Our outcomes revealed a strong biological potential of licoflavanone, whose
molecular mechanisms underlying its anti-inflammatory effects were elucidated for the first time.
2. Materials and Methods
2.1. Plant Material
Leaves of Glycyrrhiza glabra L. were collected in the Botanic Garden, University of Calabria, Rende
(Cosenza province, Southern Italy) (39◦35′74′′ N, 16◦22′94′′ E) in May 2017. The cultivation generally
requires soil 1.4 m deep or more, having a light, loamy and stone-free texture. As a perennial plant, it
is grown continuously on the same land, with pieces of stolons planted in March at 0.91 m distance.
Two prunings are necessary during the year (in May and October, generally). Fresh leaves recovered in
May [18] were used to prepare the extract named B (see later). The remaining leaves were stored at
room temperature, in the dark far from light and heat sources, for 5 months before the extraction.
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2.2. Chemical Reagents and Instrumentation
Ethanol 96%, n-hexane, and ethyl acetate (analytical grade) were obtained from Levanchimica
srl (Bari, Italy). Silica gel (0.040–0.063 and 0.063–0.200 mm) and thin-layer chromatography (TLC,
silica gel plates 60 F254) were acquired from Merck (Darmstadt, Germany). TLC were visualized at
254 nm. Ultrasound-bath Branson model 3800-CPXH (Milan, Italy) was used to perform the extractions.
Organic solutions were dried over MgSO4 and evaporated on a rotary evaporator (Büchi RII) under
reduced pressure. Melting points were obtained using a Gallenkamp melting point apparatus.
2.3. Extraction Procedures
The extract A was obtained as previously described [13]. Different procedures were performed to
obtain extracts B and C. Fresh or dried leaves (10 g), previously triturated, were extracted with ethanol
96% (250 mL) at 50 ◦C (10 cycles/s) for 1.5 h, at an ultrasonic frequency of 40 kHz. Leaves were filtered
and the solution was evaporated under reduced pressure at 40 ◦C (Figure 1). The yields of extracts,
named B, a greenish gummy resin (fresh leaves) or C, brown gummy resin (dried leaves) were 4.87 and
5.21 g, respectively.
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2.4. Chemical Characterization and Isolation of the Flavanones
Extracts B and C were analyzed via gas chromatography/mass spectrometry (GC-MS) analysis.
After dissolving samples in methanol, GC analyses were achieved by using a Shimadzu GC17AGC
equipped with HP 5MS column and a flame ionization detector (FID) controlled by Borwin Software
(Shimadzu, Milan, Italy). GC/MS analyses were completed by using a Hewlett-Packard 6890 gas
chromatograph connected to a Hewlett-Packard 5973 Mass Selective, using electron impact (EI) (Agilent
Technologies, Milan, Italy). Injector and detector temperatures were maintained at 250 ◦C. The initial
oven temperature was set at 50 ◦C for 3 min. The temperature rate was set on 10 ◦C min−1 up to 250 ◦C.
The extracts (1 g) were subjected to flash column chromatography purification (n-hexane/ethyl acetate),
in order to isolate the main components. 1H-NMR and 13C-NMR spectra of the recovered compounds
were detailed on a Bruker 300 MHz spectrometer. Chemical shifts (δ) were reported in ppm, using
tetramethylsilane (TMS) as the internal reference standard. Coupling constants were reported as a J
value in Hertz (Hz).
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2.5. Determination of Total Phenolic Content
The total phenolic content of different licorice extracts was determined using the Folin–Ciocalteu
method as previously described [26]. Briefly, 50 µg of each extract (from DMSO solution) was mixed
with 333 µL of 1:10 diluted Folin–Ciocalteu reagent, 267 µL of 10% Na2CO3 was added to the mixture,
and a final volume of 1 mL was reached by adding distilled water. Each sample was incubated for 2 h at
room temperature and the absorbance at 765 nm was measured by using a UV-Vis spectrophotometer
(Ultrospec 2100 Pro, Amersham Biosciences/GE Healthcare). A Gallic acid standard curve was used to
estimate total phenolic content of each extract, expressed as mg of gallic acid equivalents per gram
of extract.
2.6. 2,2′-diphenyl-1-picrylhydrazyl (DPPH) Assay
The 2,2′-diphenyl-1-picrylhydrazyl (DPPH) assay was performed as already reported [27]. Briefly,
different concentrations of extracts or isolated compounds were blended with 100 µL of DPPH
methanol solution (1 mM), then MeOH was added to make a final volume of 3 mL. Mixtures were
vigorously stirred and let stand in the dark for 30 min at room temperature. In each sample absorbance
decrease was evaluated at a wavelength of 517 nm, by a UV-Vis spectrophotometer (Ultrospec 2100
Pro, Amersham Biosciences/GE Healthcare).
2.7. 2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) Diammonium Salt (ABTS) Assay
The 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) Diammonium Salt (ABTS) assay was
carried out as previously described [27,28]. ABTS radical cation (ABTS• +) was attained by reacting
ABTS solution (7 mM) with potassium persulfate solution (2.45 mM) and incubating in the dark for
16 h at room temperature before use. The achieved solution was diluted using ethanol in order to reach
an absorbance of 0.70 ± 0.05 (monitored at 734 nm). Different concentrations of extracts or isolated
compounds were added to 1 mL of ABTS• + solution and mixtures were incubated under stirring in
darkness for 5 min. Absorbance was measured at 734 nm using a UV-Vis spectrophotometer (Ultrospec
2100 Pro, Amersham Biosciences/GE Healthcare).
2.8. Cell Cultures
Murine macrophages RAW 264.7 cell line was purchased from the American Culture Collection
(ATCC, Manassas, VA, USA) and cultured in Dulbecco’s modified Eagle’s medium (DMEM,
Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS, Sigma-Aldrich), 2 mM L-glutamine
(Gibco, Life Technologies) and 1% penicillin/streptomycin (Gibco, Life Technologies) at 37 ◦C in a
humidified atmosphere containing 5% CO2. Number of cell passages was kept under 15 from the
reference culture (ATCC).
2.9. Inhibition of Nitric Oxide (NO) Production in Lipopolysaccharide (LPS)-Stimulated RAW 264.7 Cells
Inhibition of NO production was assessed as previously reported [20]. Briefly, RAW 264.7 cells
were seeded at a density of 2 × 105 cells/well in 24-well plates and incubated overnight in complete
medium. Media were aspirated and replaced with fresh DMEM, then, cells were simultaneously treated
for 24 h with LPS (1 µg/mL) and different concentrations of extracts or isolated compounds. DMSO
(Sigma-Aldrich) was used as a vehicle control. After treatment, the presence of nitrite (a stable oxidized
product of NO) was measured in cell culture media by using the Griess reagent (Sigma-Aldrich).
In brief, 100 µL of cell culture supernatant were incubated with 100 µL of Griess reagent at room
temperature for 10 min in a 96-well plate, then, absorbance was measured at 550 nm using a microplate
reader (Synergy H1 microplate reader, BioTek).
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2.10. Cell Viability Assay
Cell viability was assessed quantifying the mitochondrial-dependent reduction of 3-(4,5-dimethyl-
2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) to formazan by living cells, as previously
described [29]. Briefly, RAW 264.7 cells were seeded in 24-well plates at the density of 2 × 105 cells/well,
and treated with different concentrations of extracts or isolated compounds for 24 h. At the end of the
treatment, MTT solution was added to each well (to a final concentration of 0.5 mg/mL) and plates
were incubated at 37 ◦C for 2 h until the formation of formazan crystals. Then, medium was removed,
and the formazan precipitate was solubilized in DMSO. In each well, DMSO-solubilized formazan was
quantified by reading the absorbance at 570 nm using a microplate reader (Synergy H1 microplate
reader, BioTek).
2.11. Immuno-Fluorescence Monitoring Nuclear Factor Kappa B (NF-kB) Translocation
RAW 264.7 cells were seeded on coverslip in 6-well plates at a density of 1 × 105 cells/well, and
cultured overnight in complete medium. Then, they were treated for 1 h with LPS (1 µg/mL) and extract
or licoflavanone, using their IC50 values. Next, cells were fixed with ice cold methanol for 20 min at
−20 ◦C, washed three times for 5 min with Tris buffered saline (TBS, Sigma-Aldrich), and incubated for
blocking with 5% bovine serum albumin (BSA, Sigma-Aldrich) in TBS for 40 min at 37 ◦C. Then, cells
were incubated for 40 min at 37 ◦C in anti-NF-kB p65 monoclonal antibody (Santa Cruz, Biotechnology),
diluted 1:200. After, they were washed three times for 5 min with TBS to discard the excess of primary
antibody, incubated for 40 min at 37 ◦C in anti-mouse IgG-TRITC (Sigma-Aldrich) diluted 1:300, and
subsequently washed three times for 5 min with TBS. Images at 20× magnification were taken on
Olympus BX41 microscope with CSV1.14 software, using a CAMXC-30 for image acquisition.
2.12. Real-Time RT-PCR Assays
Cells were grown in 10 cm dishes to 70–80% confluence and exposed for 6 h to the vehicle (DMSO)
or to LPS (1 µg/mL) alone or in the presence of extract C/licoflavanone at their IC50. Total cellular RNA
was extracted using TRIZOL reagent (Invitrogen), as suggested by the manufacturer. RNA purity and
integrity were assayed spectroscopically, as well as by gel electrophoresis before performing analysis.
Complementary DNA (cDNA) was synthesized by reverse transcription as already described [30].
Gene expression analyses of inducible nitric oxide synthase (iNOS), cyclooxygenase 2 (COX-2), tumor
necrosis factor alpha (TNFα) interleukin 1 beta (IL 1β) and interleukin 6 (IL 6) were performed using the
platform Quant Studio7 Flex Real-Time PCR System (Life Technologies) using SYBR Green Universal
PCR Master Mix (BioRad), according to manufacturer’s recommendations. Assays were performed in
triplicate and results were normalized using Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
mRNA levels. Relative mRNA levels were calculated using the ∆∆Ct method comparing to control
group. All the primers used for amplifications are listed in Table 1.
Table 1. qPCR primers sequences.
Primer Name Sequence (5′-3′)
iNOS-Fw CGAAACGCTTCACTTCCAA
iNOS-Rv TGAGCCTATATTGCTGTGGCT
COX2-Fw AACCGCATTGCCTCTGAAT
COX2-Rv CATGTTCCAGGAGGATGGAG
TNFa-Fw CAGGCGGTGCCTATGTCTC
TNFa –Rv CGATCACCCCGAAGTTCAGTAG
IL1b-Fw GAAATGCCACCTTTTGACAGTG
IL1b-Rv TGGATGCTCTCATCAGGACAG
IL6-Fw CTGCAAGAGACTTCCATCCAG
IL6-Rv AGTGGTATAGACAGGTCTGTTGG
GAPDH-Fw ACCACAGTCCATGCCATCAC
GAPDH-Rv TCCACCACCCTGTTGCTGTA
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2.13. Immunoblotting Analysis
RAW 264.7 cells were grown to 70–80% confluence and simultaneously treated for 2 h with LPS
(1 µg/mL) and extract or licoflavanone at their IC50. Then, cells were lysed as previously described [31],
using 200 µL of lysis buffer (50 mM Tris–HCl, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate,
2 mM sodium fluoride, 2 mM EDTA, 0.1% SDS) containing a mixture of protease inhibitors (aprotinin,
phenylmethylsulfonyl fluoride, and sodium orthovanadate; Sigma-Aldrich) useful for total protein
extraction. The same amounts of proteins were resolved on 15% SDS-polyacrylamide gel, transferred
to a nitrocellulose membrane and probed with p-p38, p-JNK and p-ERK1/2 specific antibodies (Santa
Cruz Biotechnology). Membranes were stripped and incubated with anti-GAPDH antibody in order to
confirm equal loading and transfer (Santa Cruz, Biotechnology). The antigen-antibody complex was
detected by incubation of the membranes with peroxidase-coupled goat anti-mouse or goat anti-rabbit
antibodies and revealed using the ECL System (Amersham Life Science).
2.14. Statistical Analysis
Values are expressed as means ± standard deviation of at least three replicate determinations.
Statistical analysis was performed by analysis of variance (ANOVA). Normality of each distribution
was confirmed by Shapiro–Wilk’s test, while equality of variance was verified by Levene’s test. Tukey’s
post-hoc test was used to study differences between groups. A p value≤ 0.05 was considered statistically
significant. Non-linear regression analysis was used to generate sigmoidal dose-response curves to
calculate IC50 values. Data were evaluated using GraphPad Prism 7.
3. Results and Discussion
3.1. Analysis of the Extracts and Characterization of the Isolated Compounds
The components present in the extracts B and C are summarized in Figure 2. In column
chromatography, five visible spots were visualized and isolated. Among them, only spots 2, 3 and
4 were obtained as single compounds, glabranin (M2), pinocembrin (M3) and licoflavanone (M4)
(Figure 2), and fully characterized via NMR analysis.
Spot M2. glabranin or (S)-5,7-dihydroxy-8-(3-methylbut-2-en-1-yl)-2-phenylchroman-4-one.
Amorphous white solid. clogP: 5.06285. m/z: 324 [M+]. 1H-NMR (CDCl3, 300 MHz) δ (ppm)
12.12 (s, 5-OH), 7.59–7.29 (m, 6H), 6.65 (m, 1H), 6.05 (s, 1H), 5.43 (dd, 1H, J = 3.1, 12.9 Hz), 5.20 (d, 1H,
mboxemphJ = 7.0 Hz), 3.33 (d, 1H, J = 7.0 Hz), 3.05 (dd, 1H, J = 12.9, 17.1 Hz), 2.85 (dd, 1H, J = 3.1,
17.1 Hz), 1.80 (s, 6H). 13C-NMR (CDCl3, 75 MHz) δ (ppm) 196.2, 163.7, 162.2, 159.6, 138.7, 134.6, 128.7,
128.6, 127.9, 125.9, 125.1, 121.6, 106.3, 103.3, 96.9, 78.9, 43.2, 25.7, 21.8, 17.8. These data are in agreement
with those reported [32].
Spot M3. (S)-pinocembrin or (S)-5,7-dihydroxy-2-phenylchroman-4-one). White solid m.p.:
198–199 ◦C. clogP: 3.11185. m/z: 256 [M+]. Spectroscopic data are in agreement with those reported [13,20].
Spot M4. licoflavanone or (S)-5,7-dihydroxy-2-(4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl)
chroman-4-one. Pale yellow needles m.p.: 134–135 ◦C. clogP: 4.39585. m/z: 340 [M+]. 1H-NMR (CDCl3,
300 MHz) δ (ppm) 12.0 (bs, 1H), 7.28–7.20 (m, 1H), 7.19–7.05 (m, 1H), 6.89 (d, 1H, J = 8.3 Hz), 6.05–5.75
(m, 3H), 5.25 (d, 1H, J = 3.0 Hz), 3.35 (d, 2H, J = 7.3 Hz), 3.08 (dd, 1H, J = 12.9, 17.0 Hz), 2.72 (dd, 1H,
J = 3.0, 17.0 Hz,) H-3), 1.75 (s, 6H). 13C-NMR (CDCl3, 75 MHz) δ (ppm) 196.8, 164.9, 163.7 (× 2C), 155.0,
131.5 (× 2C), 128.8, 128.5, 124.4, 123.1, 116.2, 102.8, 95.1, 94.6, 82.8, 43.2, 28.1, 24.6, 18.5. Spectroscopic
data are in agreement with those reported [23,33,34].
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3.2. Antioxidant Profile of Glycyrrhiza glabra L. Leaf Extracts and Their Flavanone-Components
In order to evaluate and compare the antioxidant power of Glycyrrhiza glabra L. leaf extracts A
B, C were subjected to DPPH and ABTS assays. In these experiments, a similar antioxidant profile
for the different extracts emerged (Figure 3), with IC50 values ranging from 13.49 to 18.05 µg/mL, in
DPPH assay, and from 5.88 to 6.76 µg/mL, in ABTS assay (Table 2), a result that reflects the similar total
phenolic content estimated for each extract (Table 3). Similar experiments were perfor d on t e t re
isolated compounds, M2, M3 and M4, to evaluate their contribution to the remarkable antioxidant
profile f the extracts. Our results highlig ted that the presence of a prenyl group can contribute
to the antioxidant profile of flavanones, according to prev ously reported studies [35]. Indeed, as
depicted in Figure 3, the presence of the prenyl group in p sition 8, characterizing glabranin (M2),
im roved by itself the poor antioxidant power of its not prenylated analogue pinocembrin (M3).
Moreover, licoflavanone (M4) showed the best antioxidant profile, suggesting that either the prenyl
group position or the presence of an additional hydroxyl group on the C ring of the flavanone backbone
could significantly modify the antioxidant power of these natural products.
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Extract A Extract B Extract C
Total phenolic content
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Extr t : xtract from fresh leaves macerat d with methanol; Extract B: extract from fresh leaves after ultrasound
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3.3. Flavanones from Glycyrrhiza glabra L. Leaf Extracts Affect NO Production in LPS-Stimulated RAW 264.7
Cell Line
A correlation between oxidative stress and inflammation had been already highlighted [36], since
several inflammatory stimuli, such as LPS, were able to promote many chronic inflammatory diseases
by activating and regulating NO production [37]. In this context, the anti-inflammatory potential of
Glycyrrhiza glabra L. leaf extracts and their flavanone components were investigated by monitoring
their ability to modulate the production of nitric oxide (NO) in LPS-stimulated RAW 264.7 cells, murine
macrophages widely used as an in vitro model to study inflammatory pathways. Firstly, we evaluated
the effect of increasing concentrations of different Glycyrrhiza glabra L. leaf extracts (ranging from 12.5
to 50 µg/mL) as well as their flavanone components (ranging from 10 to 200 µM) on LPS-stimulated
RAW 264.7 cell growth, by using MTT assay. These studies displayed that the treatment with extract C
did not elicit any significant reduction in cell viability. Conversely, the treatment with extracts A and B
reduced cell viability only at the highest tested concentrations. A comparable inhibitory effect on NO
production was also shown by using the three extracts at non-toxic concentrations. These findings are
in agreement with previous literature data reporting similar anti-inflammatory properties of Glycyrrhiza
spp. and its bioactive components, tested in our same experimental model [12]. In addition, our
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results highlighted how the ultrasound-assisted extraction, used in this study, represents a simple
and rapid alternative to the maceration process of Glycyrrhiza glabra L. leaves, guaranteeing biological
activity preservation of the phytocomplex. On the other hand, the effects of the three isolated natural
compounds were found to be significantly different from each other, both in terms of cytotoxicity and
modulation of NO production. At the tested concentrations, up to 200 µM, pinocembrin showed a
poor cytotoxic profile and a non-striking anti-inflammatory activity. On the contrary, the presence of
the prenyl group in position 8, characteristic of glabranin, determined a drastic alteration in terms of
toxicity/activity ratio, since this compound was found to be highly toxic already when used at 100 µM.
Lastly, licoflavanone displayed an intermediate cytotoxicity profile between the two other natural
compounds, but it exhibited a significant inhibitory activity on NO production, which was found at
much lower concentrations compared to that of the other tested flavanones, reaching an IC50 value of
37.68 µM (Figure 4, Table 4). On the basis of these experimental evidences and since no literature data
on the pharmacological effects of licoflavanone have been reported so far, we decided to investigate the
molecular mechanisms and cellular pathways underlying the promising anti-inflammatory potential
of this natural compound.
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IC50 ± SD (µg/mL) IC50 ± SD (µM)
Extract A Extract B Extract C M2 M3 M4
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3.4. Licoflavanone Exerts Anti-Inflammatory Effects by Reducing NF-kB Nuclear Translocation
NO is an inflammatory mediator generated by the catalytic activity of inducible nitroxide synthase
(iNOS) enzyme, whose expression is stimulated by inflammatory stimuli such as bacterial LPS through
the toll-like receptor 4 (TLR4). The induction of iNOS expression is mediated by NF-kB that is the
main transcription factor involved in inflammatory response [38]. Considering the effects exerted by
licoflavanone on NO production in LPS-stimulated RAW 264.7 cells, as well as the ability of other
flavanones (i.e., pinocembrin) to inhibit inflammatory signal transduction at NF-kB pathway level, we
tested the ability of licoflavanone to reduce the activation of this transcription factor. In particular,
after the treatment of LPS-stimulated RAW 264.7 cells, the translocation of NF-kB into the nucleus
and the expression of two of its target genes, inducible nitroxide synthase (iNOS) and cyclooxygenase
2 (COX2), were monitored. The results obtained in this study highlighted the ability of this natural
compound to reduce the translocation of NF-kB into the nucleus (Figure 5) and to significantly decrease
the transcription of its target genes (Figure 6A), so excluding that the effects on NO production were
due to a direct inhibitory action on iNOS. Such results highlight the significant role of licoflavanone
in the inhibition of NF-kB pathway observed for Glycyrrhiza glabra L. leaf extract, from which this
precious natural product was isolated.
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3.5. Licoflavanone Disrupts MAPK/NF-kB Pathway and Modulates Pro-Inflammatory Cytokines
The NF-kB pathway is interconnected with that of mitogen-activated protein kinases (MAPKs),
which mediate phosphorylation processes that lead to the activation of several transcription factors,
such as Activator Protein 1 (AP-1). These factors, together with NF-kB, activate the transcription
of different inflammatory genes, including those encoding for the pro-inflammatory cytokines that
mediate the amplification and propagation of inflammatory-mediated stress signal. On the basis
of NF-kB/MAPKs crosstalk, in this work the ability of licoflavanone to inhibit the cascade of the
main MAPKs such as p38, JNK and ERK1/2 was assessed. As shown in Figure 6B, the treatment
of LPS-stimulated RAW 264.7 cells with licoflavanone was able to rapidly cause a reduction of p38,
JNK and ERK1/2 phosphorylation and activation. Furthermore, the disruption of the NF-kB/MAPKs
signal transduction pathway, mediated by licoflavanone, was responsible for a striking reduction in
mRNA levels of several pro-inflammatory cytokines, such as Tumor Necrosis Factor alpha (TNFα),
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Interleukin-1 beta (IL 1β) and Interleukin-6 (IL 6) (Figure 6C). The pharmacological behavior of
licoflavanone was found to be in agreement with that of other plant-derived flavanones, confirming
that the ability to interfere with the MAPK/NF-kB pathway is a common feature of the different classes
of flavonoids. Similar effects, indeed, although in different experimental models, had been described
for several flavones, flavonols and flavanones, such as pinocembrin [39], naringenin [40], quercetin [41]
and luteolin [42], for which the ability to inhibit MAPKs activation, NF-kB translocation into the
nucleus, and the production of pro-inflammatory cytokines, had been reported.
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disrupts mitogen-activated protein kinases (MAPK)/NF-kB pathway and modulates pro-inflammatory
cytokines in RAW 264.7 cells. (A) Effects of extract C and M4 (both used at their IC50 values) on
inducible nitroxide synthase (iNOS) and cyclooxygenase 2 (COX2) mRNA levels. (B) Immunoblotting
analysis of phosphorylated MAPKs (p-p38, p-JNK and p-ERK) and relative quantification of expression
levels. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as loading control (C) Effects
of treatments on pro-inflammatory cytokines (Tumor Necrosis Factor alpha (TNFα), Interleukin-1 beta
(IL 1β) and Interleukin-6 (IL 6)) mRNA levels. Treatment conditions for the different experiments are
reported in the Methods (Sections 2.11 and 2.12). Values represent mean ± S.D. of three independent
experiments, each one performed with triplicate samples. * p < 0.05; ** p < 0.01; **** p < 0.001.
However, some pharmacokinetic limits of flavanoids are their partial absorption at the
gastrointestinal level, as well as that they undergo an intensive metabolic process in the liver
(methylation, sulfation, and glucuronidation), which favors their elimination, determining their low
bioavailability index [43–45]. In this regard, since in scientific literature no data are reported on the
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bioavailability of licoflavanone, it is impossible to know if this natural product could reach, in vivo,
the concentrations found to be effective in this in vitro study, therefore, future pharmacokinetic studies
will be needed.
4. Conclusions
In this report, we provide evidence that three extracts of Glycyrrhiza glabra L. leaves, as well as
three flavanones (M2, M3 and M4) isolated from them, are endowed with antioxidant properties.
In detail, the extracts obtained using different extraction techniques exhibited a similar antioxidant
profile, highlighting that UAE is a very rapid method, alternative to the maceration process, able
to provide cleaner bioactive phytocomplexes from Glycyrrhiza glabra L. leaves. Among the three
isolated compounds, licoflavanone (M4) exhibited the best antioxidant activity. On the basis of the
already reported link between antioxidant and anti-inflammatory properties [37], we also tested the
anti-inflammatory activity of our extracts and isolated flavanones.
Herein, we proved that licoflavanone inhibits LPS-induced expression of TNFα, IL 1β, and IL 6.
Furthermore, our outcomes show that licoflavanone is able to decrease iNOS and COX2 expression
levels in LPS-stimulated RAW 264.7 cells, interfering with the inflammatory cascade mediated by NO
and PGE2. Additionally, in good agreement with literature data reporting that NF-kB pathway is
interconnected with that of mitogen-activated protein kinases (MAPKs), our findings evidence that
licoflavanone treatment inhibits phosphorylation and activation levels of three important signaling
molecules belonging to the MAPK pathway (ERK1/2, JNK, and p38MAPK). Taken together, the present
findings prompt us to hypothesize that licoflavanone, gained by ultrasound-assisted extraction from
dried leaves of Glycyrrhiza Glabra L., possibly exerts its anti-inflammatory effects by interfering with
NF-kB/MAPKs crosstalk in LPS-activated macrophages. Nevertheless, further studies will be required
to deeply investigate the exact molecular target responsible for licoflavanone action and to confirm its
anti-inflammatory effects in in vivo experimental models, which are closer to human ones.
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